Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

SP2: Rapid and Automatable Contaminant Removal from Peptide Samples for Proteomic Analyses.

Waas M, Pereckas M, Jones Lipinski RA, Ashwood C, Gundry RL.

J Proteome Res. 2019 Apr 5;18(4):1644-1656. doi: 10.1021/acs.jproteome.8b00916. Epub 2019 Feb 28.

2.

Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry.

Waas M, Weerasekera R, Kropp EM, Romero-Tejeda M, Poon EN, Boheler KR, Burridge PW, Gundry RL.

Stem Cell Reports. 2019 Feb 12;12(2):395-410. doi: 10.1016/j.stemcr.2018.12.016. Epub 2019 Jan 24.

3.

Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors.

Pluimakers VG, van Waas M, Neggers SJCMM, van den Heuvel-Eibrink MM.

Crit Rev Oncol Hematol. 2019 Jan;133:129-141. doi: 10.1016/j.critrevonc.2018.10.010. Epub 2018 Nov 3. Review.

PMID:
30661649
4.

Quantitative Top-Down Mass Spectrometry Identifies Proteoforms Differentially Released during Mechanical Stimulation of Mouse Skin.

Moehring F, Waas M, Keppel TR, Rathore D, Cowie AM, Stucky CL, Gundry RL.

J Proteome Res. 2018 Aug 3;17(8):2635-2648. doi: 10.1021/acs.jproteome.8b00109. Epub 2018 Jul 6.

6.

Cell Surface Proteomics of N-Linked Glycoproteins for Typing of Human Lymphocytes.

Haverland NA, Waas M, Ntai I, Keppel T, Gundry RL, Kelleher NL.

Proteomics. 2017 Oct;17(19). doi: 10.1002/pmic.201700156.

7.

ScRu2B3 and Sc2RuB6: Borides Featuring a 2D Infinite Boron Clustering.

Salamakha LP, Sologub O, Stöger B, Rogl PF, Waas M, Kapustianyk VB, Bauer E.

Inorg Chem. 2017 Sep 5;56(17):10549-10558. doi: 10.1021/acs.inorgchem.7b01512. Epub 2017 Aug 16.

PMID:
28812877
8.

Kondo Insulator to Semimetal Transformation Tuned by Spin-Orbit Coupling.

Dzsaber S, Prochaska L, Sidorenko A, Eguchi G, Svagera R, Waas M, Prokofiev A, Si Q, Paschen S.

Phys Rev Lett. 2017 Jun 16;118(24):246601. doi: 10.1103/PhysRevLett.118.246601. Epub 2017 Jun 16.

PMID:
28665644
9.

Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy Stores.

Kropp EM, Broniowska KA, Waas M, Nycz A, Corbett JA, Gundry RL.

Stem Cells Transl Med. 2017 Apr;6(4):1191-1201. doi: 10.1002/sctm.16-0151. Epub 2017 Feb 22.

10.

Th7 Fe3 -Type Related Structures in Pd(Pt)-Cu-B Systems: Pd6 CuB3 -A New Structure Type for Borides.

Salamakha LP, Sologub O, Stöger B, Rogl PF, Waas M, Michor H, Bauer E.

Chemistry. 2017 Apr 6;23(20):4810-4817. doi: 10.1002/chem.201602767. Epub 2017 Mar 23.

PMID:
28182845
11.

N-glycoprotein surfaceome of human induced pluripotent stem cell derived hepatic endoderm.

Mallanna SK, Waas M, Duncan SA, Gundry RL.

Proteomics. 2017 Mar;17(5). doi: 10.1002/pmic.201600397. Epub 2017 Feb 1.

12.

Multiband Transport in CoSb3 Prepared by Rapid Solidification.

Ikeda M, Tomeš P, Prochaska L, Eilertsen J, Populoh S, Löffler S, Svagera R, Waas M, Sassik H, Weidenkaff A, Paschen S.

Z Anorg Allg Chem. 2015 Sep;641(11):2020-2028. Epub 2015 Sep 16.

13.

[A dyspnoeic boy with two round masses on his chest X-ray].

Simons B, van Waas M, Verhallen JT.

Ned Tijdschr Geneeskd. 2016;160:A9818. Dutch.

PMID:
26883845
14.

Mechanism of Rare Earth Incorporation and Crystal Growth of Rare Earth Containing Type-I Clathrates.

Prokofiev A, Svagera R, Waas M, Weil M, Bernardi J, Paschen S.

Cryst Growth Des. 2016 Jan 6;16(1):25-33. Epub 2015 Dec 2.

15.

Pt-B System Revisited: Pt2B, a New Structure Type of Binary Borides. Ternary WAl12-Type Derivative Borides.

Sologub O, Salamakha L, Rogl P, Stöger B, Bauer E, Bernardi J, Giester G, Waas M, Svagera R.

Inorg Chem. 2015 Nov 16;54(22):10958-65. doi: 10.1021/acs.inorgchem.5b01998. Epub 2015 Nov 2.

PMID:
26524081
16.

Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer.

den Hoed MA, Klap BC, te Winkel ML, Pieters R, van Waas M, Neggers SJ, Boot AM, Blijdorp K, van Dorp W, Pluijm SM, van den Heuvel-Eibrink MM.

Osteoporos Int. 2015 Feb;26(2):521-9. doi: 10.1007/s00198-014-2878-z. Epub 2014 Sep 11.

PMID:
25209410
17.

Transcriptional inhibition of etv2 expression is essential for embryonic cardiac development.

Schupp MO, Waas M, Chun CZ, Ramchandran R.

Dev Biol. 2014 Sep 1;393(1):71-83. doi: 10.1016/j.ydbio.2014.06.019. Epub 2014 Jun 28.

18.

N-glycoprotein surfaceomes of four developmentally distinct mouse cell types.

Kropp EM, Bhattacharya S, Waas M, Chuppa SL, Hadjantonakis AK, Boheler KR, Gundry RL.

Proteomics Clin Appl. 2014 Aug;8(7-8):603-9. doi: 10.1002/prca.201400021.

19.

Combine and conquer: surfactants, solvents, and chaotropes for robust mass spectrometry based analyses of membrane proteins.

Waas M, Bhattacharya S, Chuppa S, Wu X, Jensen DR, Omasits U, Wollscheid B, Volkman BF, Noon KR, Gundry RL.

Anal Chem. 2014 Feb 4;86(3):1551-9. doi: 10.1021/ac403185a. Epub 2014 Jan 21.

20.

Thermopower enhancement by encapsulating cerium in clathrate cages.

Prokofiev A, Sidorenko A, Hradil K, Ikeda M, Svagera R, Waas M, Winkler H, Neumaier K, Paschen S.

Nat Mater. 2013 Dec;12(12):1096-101. doi: 10.1038/nmat3756. Epub 2013 Sep 22.

PMID:
24056804
21.

Daily life physical activity in long-term survivors of nephroblastoma and neuroblastoma.

van Waas M, Wijnen M, Hartman A, de Vries AC, Pieters R, Neggers SJ, van den Heuvel-Eibrink MM.

J Pediatr Hematol Oncol. 2013 Jul;35(5):361-5. doi: 10.1097/MPH.0b013e31827e8fb9.

PMID:
23389502
22.

Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia.

Blijdorp K, van Waas M, van der Lely AJ, Pieters R, van den Heuvel-Eibrink M, Neggers S.

Leuk Res. 2013 Apr;37(4):367-71. doi: 10.1016/j.leukres.2012.12.008. Epub 2013 Jan 9.

PMID:
23312900
23.

Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors.

van Waas M, Neggers SJ, Raat H, van Rij CM, Pieters R, van den Heuvel-Eibrink MM.

PLoS One. 2012;7(12):e52237. doi: 10.1371/journal.pone.0052237. Epub 2012 Dec 14.

24.

Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors.

van Waas M, Neggers SJ, Uitterlinden AG, Blijdorp K, van der Geest IM, Pieters R, van den Heuvel-Eibrink MM.

Eur J Cancer. 2013 Feb;49(3):668-75. doi: 10.1016/j.ejca.2012.09.007. Epub 2012 Oct 1.

PMID:
23036851
25.

Adrenal function in adult long-term survivors of nephroblastoma and neuroblastoma.

van Waas M, Neggers SJ, van Eck JP, van Noesel MM, van der Lely AJ, de Jong FH, Pieters R, van den Heuvel-Eibrink MM.

Eur J Cancer. 2012 May;48(8):1159-66. doi: 10.1016/j.ejca.2012.02.046. Epub 2012 Apr 16.

26.

[Neutral zone. An anatomic space which is often neglected while fabricating removable complete dentures].

van Waas MA.

Ned Tijdschr Tandheelkd. 2011 Nov;118(11):563-7. Review. Dutch.

PMID:
22235519
27.

Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphoma.

van Waas M, Neggers SJ, Te Winkel ML, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM.

Ann Oncol. 2012 Jun;23(6):1626-32. doi: 10.1093/annonc/mdr511. Epub 2011 Nov 2.

PMID:
22048153
28.

[Dissertations 25 years after date 25. Dentures: a question of grinning and bearing it].

van Waas MA.

Ned Tijdschr Tandheelkd. 2011 May;118(5):277-81. Dutch.

PMID:
21661249
29.

Expanding soft tissue with Osmed tissue expanders in the goat maxilla.

Uijlenbroek HJ, Liu Y, He JF, Visscher C, van Waas MA, Wismeyer D.

Clin Oral Implants Res. 2011 Jan;22(1):121-8. doi: 10.1111/j.1600-0501.2010.01972.x.

PMID:
20678133
30.

The metabolic syndrome in adult survivors of childhood cancer, a review.

van Waas M, Neggers SJ, van der Lelij AJ, Pieters R, van den Heuvel-Eibrink MM.

J Pediatr Hematol Oncol. 2010 Apr;32(3):171-9. doi: 10.1097/MPH.0b013e3181d419c3. Review.

PMID:
20186100
31.

[Indications for removable partial dentures].

van Waas MA.

Ned Tijdschr Tandheelkd. 2009 Nov;116(11):593-6. Dutch.

PMID:
19999669
32.

Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer.

van Waas M, Neggers SJ, Pieters R, van den Heuvel-Eibrink MM.

Ann Oncol. 2010 May;21(5):1121-6. doi: 10.1093/annonc/mdp414. Epub 2009 Oct 22.

PMID:
19850641
33.

Effects of 5 manipulative variables on the color of ceramics used for computer-generated restorations.

Denissen H, Dozic A, van Waas M, Feilzer A.

Quintessence Int. 2007 May;38(5):401-8.

PMID:
17568839
34.

Digital videographic measurement of tooth display and lip position in smiling and speech: reliability and clinical application.

van der Geld PA, Oosterveld P, van Waas MA, Kuijpers-Jagtman AM.

Am J Orthod Dentofacial Orthop. 2007 Mar;131(3):301.e1-8.

PMID:
17346578
35.
36.

[Incorporation of implant overdentures into the dental curriculum].

van Waas MA.

Ned Tijdschr Tandheelkd. 2005 Sep;112(9):330-1. Dutch.

PMID:
16184909
37.

The oral pigmentation chart: a clinical adjunct for oral pigmentation in removable prostheses.

de Krom CJ, van Waas MA, Oosterveld P, Koopmans AS, Garrett NR.

Int J Prosthodont. 2005 Jan-Feb;18(1):66-70.

PMID:
15754895
38.

Effectiveness of preparation guidelines for an all-ceramic restorative system.

Begazo CC, van der Zel JM, van Waas MA, Feilzer AJ.

Am J Dent. 2004 Dec;17(6):437-42.

PMID:
15724757
39.

Shear bond strength of different types of luting cements to an aluminum oxide-reinforced glass ceramic core material.

Begazo CC, de Boer HD, Kleverlaan CJ, van Waas MA, Feilzer AJ.

Dent Mater. 2004 Dec;20(10):901-7.

PMID:
15501317
40.

An eight-year follow-up to a randomized clinical trial of participant satisfaction with three types of mandibular implant-retained overdentures.

Timmerman R, Stoker GT, Wismeijer D, Oosterveld P, Vermeeren JI, van Waas MA.

J Dent Res. 2004 Aug;83(8):630-3.

PMID:
15271972
41.

Microbiological and clinical effects of chlorhexidine enclosed in fixtures of 3I-Titamed implants.

Groenendijk E, Dominicus JJ, Moorer WR, Aartman IH, van Waas MA.

Clin Oral Implants Res. 2004 Apr;15(2):174-9.

PMID:
15085873
42.
43.

Effect of GBR and fixture installation on gingiva and bone levels at adjacent teeth.

Van der Zee E, Oosterveld P, Van Waas MA.

Clin Oral Implants Res. 2004 Feb;15(1):62-5.

PMID:
14731178
44.

[The smile line, a literature search].

van der Geld PA, van Waas MA.

Ned Tijdschr Tandheelkd. 2003 Sep;110(9):350-4. Dutch.

PMID:
14533342
45.

[Simulation of pigmented mucosa in complete dentures: development of an oral pigment index].

de Krom CJ, Koopmans AS, Garrett N, van Waas MA.

Ned Tijdschr Tandheelkd. 2003 Feb;110(2):69-73. Dutch.

PMID:
12621998
46.

Porcelain-veneered computer-generated partial crowns.

Denissen HW, El-Zohairy AA, van Waas MA, Feilzer AJ.

Quintessence Int. 2002 Nov-Dec;33(10):723-30.

PMID:
12553615
47.

A clinical evaluation of implants in irradiated oral cancer patients.

Visch LL, van Waas MA, Schmitz PI, Levendag PC.

J Dent Res. 2002 Dec;81(12):856-9.

PMID:
12454102
48.

[May a patient with an implant-supported partial prosthesis clean with fluoride toothpaste?].

van Waas MA, Moorer WR.

Ned Tijdschr Tandheelkd. 1999 Jan;106(1):26. Dutch. No abstract available.

PMID:
12136777
49.

[Reproducible marginal gap measurements of partial ceramic crowns].

Smeets MW, Rhemrev GE, van Waas MA, Denissen HW.

Ned Tijdschr Tandheelkd. 1999 Sep;106(9):330-3. Dutch.

PMID:
11930434
50.

[Considerations of single tooth replacement. The choice between different treatment options].

Cune MS, van Waas MA.

Ned Tijdschr Tandheelkd. 1999 May;106(5):203-7. Review. Dutch.

PMID:
11930369

Supplemental Content

Support Center